ACHIEVE LIFE SCIENCES, INC. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Achieve Life Sciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Achieve Life Sciences, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 66.1 %, a 81.8% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 66.1 -297 -81.8% Sep 30, 2024
Q2 2024 89.3 -341 -79.3% Jun 30, 2024
Q1 2024 131 -242 -64.8% Mar 31, 2024
Q4 2023 634 +442 +230% Dec 31, 2023
Q3 2023 363 +234 +181% Sep 30, 2023
Q2 2023 431 +366 +570% Jun 30, 2023
Q1 2023 373 +335 +902% Mar 31, 2023
Q4 2022 192 +169 +731% Dec 31, 2022
Q3 2022 129 +119 +1181% Sep 30, 2022
Q2 2022 64.3 +54.4 +550% Jun 30, 2022
Q1 2022 37.2 +27.5 +283% Mar 31, 2022
Q4 2021 23.1 +13.9 +150% Dec 31, 2021
Q3 2021 10.1 -1.6 -13.7% Sep 30, 2021
Q2 2021 9.89 -7.99 -44.7% Jun 30, 2021
Q1 2021 9.71 -11.7 -54.7% Mar 31, 2021
Q4 2020 9.23 -19.9 -68.3% Dec 31, 2020
Q3 2020 11.7 -19.4 -62.5% Sep 30, 2020
Q2 2020 17.9 -8.88 -33.2% Jun 30, 2020
Q1 2020 21.4 -2.15 -9.12% Mar 31, 2020
Q4 2019 29.1 +7.51 +34.8% Dec 31, 2019
Q3 2019 31.1 +11.9 +62.1% Sep 30, 2019
Q2 2019 26.8 +7.49 +38.9% Jun 30, 2019
Q1 2019 23.6 +5.1 +27.6% Mar 31, 2019
Q4 2018 21.6 +6.92 +47.1% Dec 31, 2018
Q3 2018 19.2 -3.97 -17.1% Sep 30, 2018
Q2 2018 19.3 -13.4 -41% Jun 30, 2018
Q1 2018 18.5 -24.6 -57.1% Mar 31, 2018
Q4 2017 14.7 -33.8 -69.7% Dec 31, 2017
Q3 2017 23.2 -44.5 -65.7% Sep 30, 2017
Q2 2017 32.7 -43.8 -57.3% Jun 30, 2017
Q1 2017 43.1 -54 -55.6% Mar 31, 2017
Q4 2016 48.5 -54.5 -52.9% Dec 31, 2016
Q3 2016 67.6 -11.2 -14.2% Sep 30, 2016
Q2 2016 76.5 +2.05 +2.76% Jun 30, 2016
Q1 2016 97.1 +30.9 +46.7% Mar 31, 2016
Q4 2015 103 +33.6 +48.4% Dec 31, 2015
Q3 2015 78.8 +13.9 +21.4% Sep 30, 2015
Q2 2015 74.4 +15.9 +27.2% Jun 30, 2015
Q1 2015 66.2 +21.2 +47% Mar 31, 2015
Q4 2014 69.4 +34.2 +96.9% Dec 31, 2014
Q3 2014 64.9 +35.4 +120% Sep 30, 2014
Q2 2014 58.5 +28.4 +94.4% Jun 30, 2014
Q1 2014 45 +11.2 +33.2% Mar 31, 2014
Q4 2013 35.3 -4.09 -10.4% Dec 31, 2013
Q3 2013 29.5 -23.8 -44.6% Sep 30, 2013
Q2 2013 30.1 -33.4 -52.6% Jun 30, 2013
Q1 2013 33.8 -49.3 -59.3% Mar 31, 2013
Q4 2012 39.3 Dec 31, 2012
Q3 2012 53.2 Sep 30, 2012
Q2 2012 63.5 Jun 30, 2012
Q1 2012 83.2 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.